Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salvianolate injection in primary PCI for acute myocardial infarction
ChiCTR-TRC-08000060Phase 4Completed
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of salvianolate and tirofiban in myocardial infarction (MI) (3 arms), sponsored by Shanghai Sixth People's Hospital. Primary endpoints: Myocardial contrast echocardiography, TIMI myocardial perfusion grading and 2 more. Started Mar 2008; status: completed.
02
Drugs
salvianolatetirofiban
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on ChiCTR-TRC-08000060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-08000060.